Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines.

A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines. Abstract Text:

    Influenza vaccine production has traditionally relied on the use of embryonated chicken eggs for virus isolation and propagation, but recently, cell-culture-derived manufacturing methods have been introduced. During influenza vaccine production, by either conventional or cell culture methods, there is a risk of incidental contamination by adventitious agents. Thus, a risk-assessment model has been developed to qualitatively assess the potential risk of vaccine process contamination by viral pathogens. The model takes into account the basic growth characteristics of each virus, its ability to grow in different cell substrates and resistance to processing steps during vaccine manufacture. The risk-assessment model has been applied to various pathogens to determine potential risk and relevance in different manufacturing scenarios, using different cell substrates for virus propagation, including Madin-Darby canine kidney (MDCK) cells. Avian viruses, introduced via use of embryonated eggs for virus isolation, were found to present the greatest risk, irrespective of the substrate used for influenza virus propagation. The use of MDCK cells to propagate vaccine virus from egg-isolated influenza virus strains does not introduce a new or greater adventitious virus risk, compared with egg-based vaccine production. Indeed, the adventitious virus risk is potentially reduced as fewer viruses are able to grow in MDCK cells.

    A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines. Publishing Authors By Initials

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Vaccine

    VOLUME: 26

    Page Numbers: 3297-304

    Journal Abbreviation: Vaccine

    ISSN: 0264-410X

    DAY: 15

    MONTH: 04

    YEAR: 2008

    A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8406899

    A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines.

    AFFILIATION: Novartis Behring, Emil von Behring Str. 76, D-35041 Marburg, Germany.

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Vaccine

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News